Antidepressant-like effects of central BDNF administration in mice of Antidepressant Sensitive Catalepsy (ASC) strain

Chinese Journal of Physiology

Volumn 55, Issue 4, 2012, Pages

  Tikhonova, Maria A ^a   Kulikov, Alexander V ^a   Bazovkina, Daria V ^a   Morozova, Maryana V ^a   Naumenko, Vladimir S ^a   Popova, Nina K ^a  

^a INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

Author keywords

Animal model; Antidepressant like activity; Arc mRNA; BDNF; Behavior; Mice

Indexed keywords

ACTIVITY REGULATED CYTOSKELETON ASSOCIATED PROTEIN; ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MESSENGER RNA;

ANTICATALEPTIC ACTIVITY; ANTIDEPRESSANT ACTIVITY; ANTIDEPRESSANT SENSITIVE CATALEPSY MOUSE; ARC GENE; ARTICLE; BDNF GENE; BEHAVIOR; CONTROLLED STUDY; CREB1 GENE; DEPRESSION; EXPLORATORY BEHAVIOR; FEMALE; GENE; HEREDITY; HIPPOCAMPUS; IMMOBILIZATION; LOCOMOTION; MALE; MOUSE; MOUSE STRAIN; NERVE CELL PLASTICITY; NONHUMAN; POLR2A GENE; PREFRONTAL CORTEX; SEXUAL FUNCTION; SOCIAL INTERACTION; SOCIAL INTEREST; SUSPENSION; TAIL; TPH1 GENE; ANIMAL; ANIMAL BEHAVIOR; CATALEPSY; METABOLISM;

ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; BRAIN-DERIVED NEUROTROPHIC FACTOR; CATALEPSY; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DEPRESSIVE DISORDER; HIPPOCAMPUS; MICE;

EID: 84864474548     PISSN: 03044920     EISSN: 26660059     Source Type: Journal    
DOI: 10.4077/CJP.2012.BAA041     Document Type: Article

References (63)

1. Aid, T., Kazantseva, A., Piirsoo, M., Palm, K. and Timmusk, T. Mouse and rat BDNF gene structure and expression revisited. J. Neurosci. Res. 85: 525-535, 2007.
2. Alme, M.N., Wibrand, K., Dagestad, G. and Bramham, C.R. Chronic fluoxetine treatment induces brain region-specific upregulation of genes associated with BDNF-induced long-term potentiation. Neural Plast. 2007:26496, 2007.
3. Alperina, E.L., Kulikov, A.V., Popova, N.K. and Idova, G.V. Immnune response in mice of a new strain ASC (antidepressants sensitive catalepsy). Bull. Exp. Biol. Med. 144: 221-223, 2007.
4. Amstislavskaia, T.G., Gladkikh, D.V., Belousova, I.I., Maslova, L.N. and Popova, N.K. The influence of sexual experience on sexual motivation and copulatory behavior in male rats. [In Russian]. Ross. Fiziol. Zh. Im. I. M. Sechenova. 96: 154-162, 2010.
5. Amstislavskaya, T.G. and Popova, N.K. Female-induced sexual arousal in male mice and rats: behavioral and testosterone response. Horm. Behav. 46: 544-550, 2004.
6. Balu, D.T., Hoshaw, B.A., Malberg, J.E., Rosenzweig-Lipson, S., Schechter, L.E. and Lucki, I. Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments. Brain Res. 1211: 37-43, 2008.
7. Barde, Y.A. The nerve growth factor family. Prog. Growth Factor Res. 2: 237-248, 1990.
8. Bazovkina, D.V., Kulikova, A.V., Kondaurova, E.M. and Popova, N.K. Selection for the predisposition to catalepsy enhances depressive-like traits in mice. [In Russian]. Genetika. 41: 1222-1228, 2005.
9. Bramham, C.R., Worley, P.F., Moore, M.J. and Guzowski, J.F. The immediate early gene arc/arg3.1: regulation, mechanisms, and function. J. Neurosci. 28: 11760-11767, 2008.
10. Brunoni, A.R., Lopes, M. and Fregni, F. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int. J. Neuropsychopharmacol. 11: 1169-1180, 2008.
11. Castren, E. Neurotrophic effects of antidepressant drugs. Curr. Opin. Pharmacol. 4: 58-64, 2004.
12. Castren, E. and Rantamaki, T. The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity. Dev. Neurobiol. 70: 289-297, 2010.
13. Castro, E., Tordera, R.M., Hughes, Z.A., Pei, Q. and Sharp, T. Use of Arc expression as a molecular marker of increased postsynaptic 5-HT function after SSRI/5-HT1A receptor antagonist coadministration. J. Neurochem. 85: 1480-1487, 2003.
14. Clayton, A.H. and Montejo, A.L. Major depressive disorder, antidepressants, and sexual dysfunction. J. Clin. Psychiatry. 67 Suppl 6: 33-37, 2006.
15. Cryan, J.F., Markou, A. and Lucki, I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol. Sci. 23: 238-245, 2002.
16. De Foubert, G., Carney, S.L., Robinson, C.S., Destexhe, E.J., Tomlinson, R., Hicks, C.A., Murray, T.K., Gaillard, J.P., Deville, C., Xhenseval, V., Thomas, C.E., O'Neill, M.J. and Zetterstrom, T.S. Fluoxetine-induced change in rat brain expression of brainderived neurotrophic factor varies depending on length of treatment. Neuroscience 128: 597-604, 2004.
17. Dixon, A.K. Ethological strategies for defence in animals and humans: their role in some psychiatric disorders. Brit. J. Med. Psychol. 71: 417-445, 1998.
18. Dubrovina, N.I., Zinov'ev, D.R., Zinov'eva, D.V. and Kulikov, A.V. Learning and extinction of a passive avoidance response in mice with high levels of predisposition to catalepsy. Neurosci. Behav. Physiol. 39: 475-480, 2009.
19. El-Sayed, M., Hofman-Bang, J. and Mikkelsen, J.D. Effect of brain-derived neurotrophic factor on activity-regulated cytoskeleton-associated protein gene expression in primary frontal cortical neurons. Comparison with NMDA and AMPA. Eur. J. Pharmacol. 660: 351-357, 2011.
20. Finkbeiner, S., Tavazoie, S.F., Maloratsky, A., Jacobs, K.M., Harris, K.M. and Greenberg, M.E. CREB: a major mediator of neuronal neurotrophin responses. Neuron 19: 1031-1047, 1997.
21. Gourley, S.L., Kiraly, D.D., Howell, J.L., Olausson, P. and Taylor, J.R. Acute hippocampal brain-derived neurotrophic factor restores motivational and forced swim performance after corticosterone. Biol. Psychiatry. 64: 884-890, 2008.
22. Greenwood, B.N., Strong, P.V., Foley, T.E., Thompson, R.S. and Fleshner, M. Learned helplessness is independent of levels of brain-derived neurotrophic factor in the hippocampus. Neuroscience 144: 1193-1208, 2007.
23. Gregorian, R.S., Golden, K.A., Bahce, A., Goodman, C., Kwong, W.J. and Khan, Z.M. Antidepressant-induced sexual dysfunction. Ann. Pharmacother. 36: 1577-1589, 2002.
24. Hellweg, R., Ziegenhorn, A., Heuser, I. and Deuschle, M. Serum concentrations of nerve growth factor and brain-derived neurotrophic factor in depressed patients before and after antidepressant treatment. Pharmacopsychiatry 41: 66-71, 2008.
25. Henry, C.J., Huang, Y., Wynne, A., Hanke, M., Himler, J., Bailey, M.T., Sheridan, J.F. and Godbout, J.P. Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia. J. Neuroinflammation. 5: 15, 2008.
26. Hoshaw, B.A., Malberg, J.E. and Lucki, I. Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects. Brain Res. 1037: 204-208, 2005.
27. Itoh, T., Tokumura, M. and Abe, K. Effects of rolipram, a phosphodiesterase 4 inhibitor, in combination with imipramine on depressive behavior, CRE-binding activity and BDNF level in learned helplessness rats. Eur. J. Pharmacol. 498: 135-142, 2000
28. Ji, Y., Lu, Y., Yang, F., Shen, W., Tang, T.T., Feng, L., Duan, S. and Lu, B. Acute and gradual increases in BDNF concentration elicit distinct signaling and functions in neurons. Nat. Neurosci. 13: 302-309, 2010.
29. Klemm, W.R. Drug effects on active immobility responses: what they tell us about neurotransmitter systems and motor functions. Prog. Neurobiol. 32: 403-422, 1989.
30. Kondaurova, E.M., Bazovkina, D.V., Kulikov, A.V. and Popova, N.K. Selective breeding for catalepsy changes the distribution of microsatellite D13Mit76 alleles linked to the 5-HT serotonin receptor gene in mice. Genes Brain Behav. 5: 596-601, 2006.
31. Kulikov, A.V., Kozlachkova, E.Y., Maslova, G.B. and Popova, N.K. Inheritance of predisposition to catalepsy in mice. Behav. Genet. 23: 379-384, 1993.
32. Kulikov, A.V., Naumenko, V.S., Voronova, I.P., Tikhonova, M.A. and Popova, N.K. Quantitative RT-PCR assay of 5-HT1A and 5-HT2A serotonin receptor mRNAs using genomic DNA as an external standard. J. Neurosci. Methods. 141: 97-101, 2005.
33. Kulikov, A.V., Kolpakov, V.G. and Popova, N.K. The genetic cataleptic (GC) rat strain as a model of depressive disorders. In: Animal Models in Biological Psychiatry, edited by Kaluev, A.V. New York: Nova Science Publishers, 2006, pp. 59-73.
34. Kulikov, A.V., Bazovkina, D.V., Kondaurova, E.M. and Popova, N.K. Genetic structure of hereditary catalepsy in mice. Genes Brain Behav. 7: 506-512, 2008.
35. Kulikov, A.V. and Popova, N.K. Genetic Control of Catalepsy in Mice. In: Genetic Predisposition to Disease, edited by Torres, S.L., Marin, M.S. NewYork: Nova Science Publishers, 2008, pp. 215-236.
36. Kulikov, A.V., Tikhonova, M.A. and Kulikov, V.A. Automated measurement of spatial preference in the open field test with transmitted lighting. J. Neurosci. Methods. 170: 345-351, 2008.
37. Larsen, M.H., Rosenbrock, H., Sams-Dodd, F. and Mikkelsen, J.D. Expression of brain derived neurotrophic factor, activity-regulated cytoskeleton protein mRNA, and enhancement of adult hippocampal neurogenesis in rats after sub-chronic and chronic treatment with the triple monoamine re-uptake inhibitor tesofensine. Eur. J. Pharmacol. 555: 115-121, 2007.
38. Lee, H.Y. and Kim, Y.K. Plasma brain-derived neurotrophic factor as a peripheral marker for the action mechanism of antidepressants. Neuropsychobiology 57: 194-199, 2008.
39. Messaoudi, E., Kanhema, T., Soule, J., Tiron, A., Dagyte, G., da Silva, B. and Bramham, C.R. Sustained Arc/Arg3.1 synthesis controls long-term potentiation consolidation through regulation of local actin polymerization in the dentate gyrus in vivo. J. Neurosci. 27: 10445-10455, 2007.
40. Naumenko, V.S. and Kulikov, A.V. Quantitative assay of 5-HT (1A) serotonin receptor gene expression in the brain. Mol. Biol. (Mosk). 40: 37-44, 2006.
41. Naumenko, V.S., Osipova, D.V., Kostina, E.V. and Kulikov, A.V. Utilization of a two-standard system in real-time PCR for quantification of gene expression in the brain. J. Neurosci. Methods 170: 197-203, 2008.
42. Naumenko, V.S., Bazovkina, D.V., Kondaurova, E.M., Zubkov, E.A. and Kulikov, A.V. The role of 5-HT2A receptor and 5-HT2A/ 5-HT1A receptor interaction in the suppression of catalepsy. Genes Brain Behav. 9: 519-524, 2010.
43. Nibuya, M., Morinobu, S. and Duman, R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J. Neurosci. 15: 7539-7547, 1995.
44. Pei, Q., Zetterstrom, T.S., Sprakes, M., Tordera, R. and Sharp, T. Antidepressant drug treatment induces Arc gene expression in the rat brain. Neuroscience 121: 975-982, 2003.
45. Pittenger, C. and Duman, R.S. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 33: 88-109, 2008.
46. Rogoz, Z. and Legutko, B. Combined treatment with imipramine and metyrapone induces hippocampal and cortical brain-derived neurotrophic factor gene expression in rats. Pharmacol. Rep. 57: 840-844, 2005.
47. Sanberg, P.R., Bunsey, M.D., Giordano, M. and Norman, A.B. The catalepsy test: its ups and downs. Behav. Neurosci. 102: 748-759, 1988.
48. Schmidt, H.D., Banasr, M. and Duman, R.S. Future Antidepressant Targets: Neurotrophic Factors and Related Signaling Cascades. Drug Discov. Today Ther. Strateg. 5: 151-156, 2008.
49. Sen, S., Duman, R. and Sanacora, G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol. Psychiatry. 64: 527-532, 2008.
50. Shirayama, Y., Chen, A.C., Nakagawa, S., Russell, D.S. and Duman, R.S. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J. Neurosci. 22: 3251-3261, 2002.
51. Singerman, B. and Raheja, R. Malignant catatonia-a continuing reality. Ann. Clin. Psychiatry. 6: 259-266, 1994.
52. Sinovyev, D.R., Dubrovina, N.I. and Kulikov, A.V. Development of amnesia in different mouse strains. Bull. Exp. Biol. Med. 147: 557-559, 2009.
53. Sirianni, R.W., Olausson, P., Chiu, A.S., Taylor, J.R. and Saltzman, W.M. The behavioral and biochemical effects of BDNF containing polymers implanted in the hippocampus of rats. Brain Res. 1321: 40-50, 2010.
54. Soule, J., Messaoudi, E. and Bramham, C.R. Brain-derived neurotrophic factor and control of synaptic consolidation in the adult brain. Biochem. Soc. Trans. 34: 600-604, 2006.
55. Taylor, M.A. and Fink, M. Catatonia in psychiatric classification: a home of its own. Am. J. Psychiatry. 160: 1233-1241, 2003.
56. Thome, J., Sakai, N., Shin, K., Steffen, C., Zhang, Y.J., Impey, S., Storm, D. and Duman, R.S. cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. J. Neurosci. 20: 4030-4036, 2000.
57. Tikhonova, M.A., Lebedeva, V.V., Kulikov, A.V., Bazovkina, D.V. and Popova, N.K. Effect of imipramine on the behavior and cerebral 5-HT1A serotonin receptors in mice genetically predisposed to catalepsy. Bull. Exp. Biol. Med. 141: 48-50, 2006.
58. Tikhonova, M.A., Kulikov, A.V., Naumenko, V.S., Morozova, M.V., Bazovkina, D.V. and Popova, N.K. Intracerebral administration of brain-derived neurotrophic factor (BDNF) reduces severity of cataleptic freezing in mice with genetic predisposition to catalepsy. Bull. Exp. Biol. Med. 148: 889-891, 2009.
59. Tikhonova, M.A., Alperina, E.L., Tolstikova, T.G., Bazovkina, D.V., Di, V.Y., Idova, G.V., Kulikov, A.V. and Popova, N.K. Effects of chronic fluoxetine treatment on catalepsy and the immune response in mice with a genetic predisposition to freezing reactions: the roles of types 1A and 2A serotonin receptors and the tph2 and SERT genes. Neurosci. Behav. Physiol. 40: 521-527, 2010.
60. Tikhonova, M.A., Otroshchenko, E.A. and Kulikov, A.V. Effects of chronic fluoxetine treatment on manifestation of sexual motivation and social behavior in mice of ASC line. [In Russian]. Ross. Fiziol. Zh. Im. I. M. Sechenova. 96: 163-172, 2010.
61. Vishnivetskaya, G.B., Skrinskaya, J.A., Seif, I. and Popova, N.K. Effect of MAO A deficiency on different kinds of aggression and social investigation in mice. Aggress. Behav. 33: 1-6, 2007.
62. Wibrand, K., Messaoudi, E., Havik, B., Steenslid, V., Lovlie, R., Steen, V.M. and Bramham, C.R. Identification of genes coupregulated with Arc during BDNF-induced long-term potentiation in adult rat dentate gyrus in vivo. Eur. J. Neurosci. 23: 1501-1511, 2006.
63. Ying, S.W., Futter, M., Rosenblum, K., Webber, M.J., Hunt, S.P., Bliss, T.V. and Bramham, C.R. Brain-derived neurotrophic factor induces long-term potentiation in intact adult hippocampus: requirement for ERK activation coupled to CREB and upregulation of Arc synthesis. J. Neurosci. 22: 1532-1540, 2002.